STOK Logo

Stoke Therapeutics, Inc. (STOK) 

NASDAQ$9
Market Cap
$476.7M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
860 of 924
Rank in Industry
489 of 527

STOK Insider Trading Activity

STOK Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$96,483,61629100

Related Transactions

Tulipano Stephen JCFO0$01$25,102$-25,102
Allan JonathanGENERAL COUNSEL & CORP SEC0$05$521,189$-521,189
Kaye Edward M. MDCEO0$04$888,524$-888,524
Ticho BarryCHIEF MEDICAL OFFICER0$012$1.43M$-1.43M
Nash Huw M.COO & CBO0$04$1.64M$-1.64M
Skorpios Trust10 percent owner0$03$91.98M$-91.98M

About Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the â€¦

Insider Activity of Stoke Therapeutics, Inc.

Over the last 12 months, insiders at Stoke Therapeutics, Inc. have bought $0 and sold $96.48M worth of Stoke Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Stoke Therapeutics, Inc. have bought $29.25M and sold $23.52M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 375,000 shares for transaction amount of $14.63M was made by Harrison Seth Loring () on 2020‑11‑24.

List of Insider Buy and Sell Transactions, Stoke Therapeutics, Inc.

2024-12-23SaleSkorpios Trust10 percent owner
2M
3.6956%
$11.50$23M-15.59%
2024-12-09SaleKaye Edward M. MDCEO
6,786
0.0122%
$12.99$88,158-25.00%
2024-12-09SaleTicho BarryCHIEF MEDICAL OFFICER
2,586
0.0046%
$12.99$33,596-25.00%
2024-12-09SaleAllan JonathanGENERAL COUNSEL & CORP SEC
13,666
0.0256%
$13.61$185,978-25.00%
2024-12-06SaleKaye Edward M. MDCEO
6,170
0.0113%
$12.78$78,837-21.51%
2024-12-06SaleTicho BarryCHIEF MEDICAL OFFICER
13,945
0.0256%
$12.78$178,182-21.51%
2024-12-06SaleAllan JonathanGENERAL COUNSEL & CORP SEC
9,696
0.0178%
$12.78$123,891-21.51%
2024-12-02SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.0187%
$12.07$120,698-12.51%
2024-11-01SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.0187%
$12.68$126,803-13.80%
2024-10-01SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.0187%
$12.06$120,648-7.60%
2024-09-19SaleSkorpios Trust10 percent owner
1.94M
3.4152%
$14.05$27.22M-23.32%
2024-09-03SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.0189%
$14.95$149,481-21.42%
2024-08-01SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.019%
$14.58$145,843-17.80%
2024-07-02SaleNash Huw M.Chief Business Officer
2,500
0.0049%
$13.11$32,779-3.62%
2024-07-01SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.0204%
$13.75$137,458-10.81%
2024-06-03SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.0189%
$15.22$152,185-17.83%
2024-05-20SaleKaye Edward M. MDCEO
42,350
0.0779%
$15.43$653,529-20.31%
2024-05-20SaleAllan JonathanGENERAL COUNSEL & CORP SEC
8,599
0.0154%
$15.04$129,327-20.31%
2024-05-20SaleNash Huw M.COO & CBO
50,000
0.0917%
$15.39$769,500-20.31%
2024-05-01SaleTicho BarryCHIEF MEDICAL OFFICER
10,000
0.0189%
$11.37$113,653+10.55%
Total: 104
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Harrison Seth Loring
17161713
32.4008%
$154.46M20<0.0001%
Apple Tree Partners IV, L.P.10 percent owner
17161713
32.4008%
$154.46M20<0.0001%
RTW INVESTMENTS, LP10 percent owner
3544248
6.6914%
$31.9M61<0.0001%

Historical Insider Profitability vs. Competitors

$587,109,125
90
3.17%
$521.31M
$14,527,743
76
38.40%
$482.25M
$24,384,691
42
-30.27%
$459.77M
$6,280,187
19
6.80%
$493.08M
$100,566,697
18
-5.10%
$455.67M

STOK Institutional Investors: Active Positions

Increased Positions68+49.64%9M+14.99%
Decreased Positions58-42.34%6M-9.92%
New Positions29New7MNew
Sold Out Positions17Sold Out257,411Sold Out
Total Postitions147+7.3%61M+5.07%

STOK Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Skorpios Trust$59,393.0013.03%6.91M-2M-22.46%2024-12-31
Blackrock, Inc.$50,633.0011.11%5.89M+317,361+5.7%2024-12-31
Lynx1 Capital Management Lp$44,610.009.79%5.19M00%2024-12-31
Rtw Investments, Lp$44,062.009.67%5.12M+471,240+10.13%2024-12-31
Baker Bros. Advisors Lp$39,851.008.74%4.63M+265,395+6.08%2024-12-31
Redmile Group, Llc$39,505.008.67%4.59M-119,880-2.54%2024-12-31
Morgan Stanley$29,560.006.49%3.44M-768,063-18.26%2024-12-31
Cowen And Company, Llc$27,903.006.12%3.24M-121,246-3.6%2024-09-30
Toronto Dominion Bank$27,290.005.99%3.17M+3MNew2024-12-31
Vanguard Group Inc$23,488.005.15%2.73M-28,049-1.02%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.